# Medicopharm AG

Company profile · SME (from the award notice)

- Legal form: AG
- Seat: Nußdorf am Inn, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 September 2024.

## Identifiers

- Register entry: HRB 14706
- Register entry: HRB 4706

As the covered sources state them.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
| --- | ---: | ---: | ---: | ---: | --- | --- |
| 33 Medical equipments, pharmaceuticals and personal care products | 2 | — | 1 | 1 | 1 September 2024 | 1 September 2024 |

Based on the notices and sources Inteliwert covers; not a complete record.

### Awards

- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2024 - 31.08.2025 (zzgl. Verlängerungsoption 1x12 Monate)](https://inteliwert.com/tender/opp_0VG3YK645T4CKR7WZ9XAET6NGA/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum)  
  Buyer: DAK-Gesundheit · Awarded: 1 September 2024 · CPV 33600000
- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026](https://inteliwert.com/tender/opp_A5DXJ7B2B81HYW94CMKWKAZ143/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum)  
  Buyer: DAK-Gesundheit · Awarded: 1 September 2024 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Open House Biologika Rabattverträge 2026 - 34 Imiglucerase](https://inteliwert.com/tender/opp_5FMMEC2PMGS72JGFX4Y8WT1MYC/open-house-biologika-rabattvertraege-2026-34-imiglucerase)  
  Open · SME (from the award notice) · Buyer: Techniker Krankenkasse · Deadline: 31 Dec 2028, 23:58 (UTC+01:00) · [Official notice](https://ted.europa.eu/de/notice/-/detail/772971-2026), Last checked 7 Nov 2026, 07:11 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_A5DXJ7B2B81HYW94CMKWKAZ143/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_VECBH6QY9JFKWYXGXXHBC8D7HD), checked 7 Nov 2026
  - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_A5DXJ7B2B81HYW94CMKWKAZ143/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026
- [Open-House-Rabattverträge 2026-16 (aut idem)](https://inteliwert.com/tender/opp_JX7M0F0A9VVJXAJM608F4D3ZD8/open-house-rabattvertraege-2026-16-aut-idem)  
  Open · SME (from the award notice) · Buyer: Techniker Krankenkasse · Deadline: 31 Oct 2029, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/40c9e4b5-4c07-4e5e-84cb-d38bf3716628), Last checked 7 Nov 2026, 06:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_A5DXJ7B2B81HYW94CMKWKAZ143/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_VECBH6QY9JFKWYXGXXHBC8D7HD), checked 7 Nov 2026
  - 2 awards in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_A5DXJ7B2B81HYW94CMKWKAZ143/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 7 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 September 2024.

---

Page: https://inteliwert.com/company/org_VECBH6QY9JFKWYXGXXHBC8D7HD/medicopharm-ag

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.
